Henry Ji
Modulasetulo, Mopresidente le CEO
- Lilemo tse 25+ tsa boiphihlelo indastering ea biotechnology le mahlale a bophelo
- Dr. Ji o thehile Sorrento mme o sebelitse e le motsamaisi ho tloha 2006, CEO le Mopresidente ho tloha 2012, le Molula-setulo ho tloha 2017.
- Nakong ea nako ea hae Sorrento, o thehile le ho etella pele kholo e makatsang ea Sorrento ka ho fumana le ho kopanya ho kenyelletsa Bioserv, Scilex Pharmaceuticals, Concortis Biotherapeutics, Levena Biopharma, LACEL, TNK Therapeutics, Virttu Biologics, Ark Animal Health, le Sofurysa Systems Lymphatic.
- O sebelitse joalo ka Ofisiri e ka Sehloohong ea Saense ea Sorrento ho tloha 2008 ho isa 2012 hape e le CEO oa Nako ea nakoana ho tloha 2011 ho isa 2012.
- Pele ho Sorrento, o ne a tšoere maemo a phahameng ho CombiMatrix, Stratagene hape a theha Stratagene Genomics, e leng setsi sa Stratagene, mme a sebetsa joalo ka Mopresidente le CEO le Motsamaisi oa Boto.
- BS le Ph.D.
Kwala >
Mike Royal
Motsamaisi e Moholo oa Bongaka
- Dr. Royal ke mookameli oa meriana ea nang le lilemo tse 20 tsa tsoelo-pele ea bongaka le litaba tsa bongaka. Haufinyane tjena, e ne e le Ofisiri e ka Sehloohong ea Bongaka ea Suzhou Connect Biopharmaceuticals le, pele ho moo, Concentric Analgesics. O ikopanya le Sorrento moo pele e neng e le EVP, Clinical Development and Regulatory Affairs ka 2016.
- O bile le boikarabello kapa ho kenya letsoho ho li-NDA tse 'maloa tse atlehileng, ho kenyeletsoa NCEs, 505(b) (2)s le ANDAs.
- Dr. Royal ke boto e tiisitsoeng ka meriana ea ka hare, meriana ea bohloko, anesthesiology e nang le mangolo a eketsehileng a ho laola bohloko, meriana ea ho lemalla le meriana ea molao.
- E 'nile ea e-ba Motlatsi oa Moprofesa oa Bongaka Univesithing ea Uniformed Services University of Health Sciences, Motlatsi oa Motlatsi oa Anesthesiology / Critical Care Medicine Univesithing ea Pittsburgh Medical Center, le Moprofesa oa Adjunct Univesithing ea Oklahoma le Univesithi ea California San Diego.
- O hatisitse haholo ka likhaolo tsa libuka tse fetang 190, lingoloa tse hlahlobiloeng ke lithaka le lipapiso / li-poster; mme e bile sebui se memilweng dikopanong tsa naha le tsa matjhaba
- BS, MD, JD, MBA
Kwala >
Elizabeth Czerepak
Motlatsi oa Mopresidente oa Phethahatso, Ofisiri e ka Sehloohong ea Lichelete, Ofisiri e ka Sehloohong ea Khoebo
- Lilemo tse 35+ tsa boiphihlelo ba lichelete le ts'ebetso ho biotech le meriana
- Mme Czerepak o qetile lilemo tse 18 a le Pharma e kholo le lilemo tse 11 e le CFO ea li-biotechs tse fapaneng, moo a ileng a etella pele matsapa a lichelete, a kopanelo le a M&A. O qalile mosebetsi oa hae ho Merck & Co., a bapala karolo ea bohlokoa ho fumaneng Syntex ea $5.4B ea Roche, mme a etella pele matsapa a kopanelo bakeng sa Humira® e ileng ea fella ka thekiso ea BASF Pharma ea $6.8B ho Abbott.
- Ka lilemo tse robong e le Mookameli oa JP Morgan le Bear Stearns, o ne a theha molekane oa kakaretso oa letlole la khoebo la $212M, moo a ileng a etella pele matsete ho li-biotechs tse 13, a sebetsa libotong le ho thusa ho tsoa ka IPO le ho fumana. Series 7 le Series 63 FINRA (NASD) Moemeli ea Ngolisitsoeng ho tloha 2001 ho isa 2008.
- Setho sa boto e nang le boiphihlelo (ho kenyeletsoa Sorrento le Scilex) le molula-setulo oa tlhahlobo, ba fumanang Setifikeiti sa Motsamaisi oa Khoebo ho tsoa Sekolong sa Khoebo sa Harvard ka 2020.
- BA le MBA
Kwala >
Mark R. Brunswick
Motlatsi oa Mopresidente e Moholo oa Litaba tsa Taolo
- Dr. Brunswick o na le lilemo tse fetang 35 tsa maemo a phahameng Lefapheng le Laoloang ho kenyeletsoa lilemo tse fetang 9 ho US FDA, Center for Biologics, Division of Monoclonal Antibodies.
- Pele a kenela Sorrento, Dr. Brunswick e ne e le Hlooho ea Litaba tsa Taolo le Boleng ho Sophiris Bio, k'hamphani e etsang moriana bakeng sa benign prostatic hyperplasia le mofets'e oa senya. Pele ho moo e ne e le hlooho ea Regulatory Affairs Arena Pharmaceuticals e sebetsanang le liphekolo tse lebisitsoeng ho G Protein receptors.
- Dr. Brunswick o ile a etella pele sehlopha sa taolo ho Elan Pharmaceuticals se shebaneng le Lefu la Alzheimer le motsoako oa bohloko, ziconotide.
- BS le Ph.D.
Kwala >
Robert D. Allen
Motlatsi oa Moporesidente e Moholo R&D
- Dr. Allen o qetile lilemo tse fetang 15 indastering ea biotechnology e etellang pele lipatlisiso, nts'etsopele ea pele ho bongaka, le tlhahiso ea pele ea bongaka ea meriana e thibelang likokoana-hloko le e thibelang mofetše.
- Pele a kenela Sorrento, Dr. Allen o sebelitse e le Motsamaisi oa Saense oa Oregon Translational Research and Development Institute (OTRADI), a sebelisana le indasteri le balekane ba thuto mabapi le ho sibolla lithethefatsi le matšolo a profiling a mokhethoa a shebaneng le mofets'e oa hematologic, lihlahala tse tiileng, le likokoana-hloko tsa mafu a tšoaetsanoang.
- Pele ho OTRADI, Dr. Allen o ile a qapa mananeo a sibollo ho SIGA Technologies a khethollang li-antiviral tse sebetsanang ka ho toba le livaerase malapeng a bunyavirus le filovirus hammoho le mehato e laoloang ke batho ba bangata khahlanong le likokoana-hloko tse ngata tsa batho le ho tlama libaktheria tsa intracellular.
- BS le Ph.D.
Kwala >
Xiao Xu
Mopresidente ACEA
- Dr. Xu o na le boiphihlelo ba lilemo tse fetang 20 e le molaoli oa liindasteri tsa biotech. Dr. Xu e ne e le mothehi-mmoho, mopresidente le CEO oa ACEA Biosciences (e fumanoeng ke Agilent ka 2018) le ACEA Therapeutics (e fumanoeng ke Sorrento Therapeutics ka 2021). O kena Sorrento Therapeutics ka mor'a ho fumana thepa, 'me e tsoela pele ho sebetsa e le Mopresidente oa ACEA, e leng setsi sa Sorrento Therapeutics.
- O ntse a laola le ho ikarabella bakeng sa nts'etsopele ea lipeipi tsa lithethefatsi tsa ACEA, lithuto tsa bongaka, le setsi sa tlhahiso ea cGMP.
- E ne e le eena moqapi-'moho oa theknoloji ea lisebelisoa tsa selefouno e sa lefelloeng 'me a ikarabella bakeng sa theknoloji / nts'etsopele ea lihlahisoa le tšebelisano ea khoebo le Roche Diagnosis, khoebo ea lefats'e ea thekenoloji le lihlahisoa tsa ACEA, le $ 250 milione ea Agilent ea ACEA Biosciences.
- E bile mofuputsi oa basebetsi le rasaense oa lipatlisiso ho Gladstone Institutes, The Scripps Research Institute le US Centers for Disease Control and Prevention. O na le litokelo tse fetang 50 tsa litokelo tsa molao tsa US le likopo tsa patent mme o phatlalalitse lingoloa tsa lipatlisiso tse fetang 60 likoranteng tsa machabeng, ho kenyeletsoa Science, PNAS, Nature Biotechnology, le Chemistry le Biology.
- BS, MS, le MD
Kwala >
Shawn Sahebi
Motlatsi oa Mopresidente e Moholo oa Ts'ebetso ea Khoebo
- Dr. Sahebi o etella pele mesebetsi ea khoebo ea Sorrento
- E tlisa lilemo tse fetang 30 tsa boiphihlelo ba meriana ho kenyelletsa saense ea ho bapatsa le leano la khoebo ho Sorrento
- Pele a kenella Sorrento, o ne a tšoere maemo a phahameng a botsamaisi le Novartis, Pfizer le Lilly ba nts'etsapele litlhahlobo tsa khoebo le maano a ho bapatsa a tsamaisoang ke data a ikarabellang bakeng sa kholo e kholo ea thekiso ea lihlahisoa tse fetang 20 tse fihletseng boemo ba blockbuster libakeng tsa Cardiovascular, Arthritis, Neuroscience, Lefu la tsoekere le Oncology.
- Molumeli ea tiileng oa hore litso tse kopanetsoeng li theha lihlopha tse hlolang
- Mopresidente oa nakong e fetileng, Mokhatlo oa Amerika oa Tsamaiso ea Litlhare
- BA, MBA le Ph.D.
Kwala >
Brian Cooley
Motlatsi oa Moporesidente e Moholo, Khokahano ea Khoebo le Ntlafatso ea Lithethefatsi ea Lymphatic BU
- Lilemo tse 30+ tsa boiphihlelo indastering ea biopharmaceutical le saense ea bophelo
- Mong. Cooley o ile a tšoara maemo a fapa-fapaneng a ho rekisa, a ho bapatsa le a boetapele ba khoebo lik'hamphaning tse 500 tse ruileng mme o etelletse pele ho bokella chelete le ho qala boiteko ba lik'hamphani tsa theknoloji ea tlhokomelo ea bophelo.
- Pele a kenella Sorrento, Monghali Cooley o ile a etella pele boiteko ba ho qala lihlahisoa tse ncha lefatšeng ka bophara ka boikarabello ba P&L ho Eli Lilly le Company le Genentech libakeng tsa mafu ho kenyelletsa lefu la tsoekere, Neurology, Immunology le Rare Disease.
- Ho feta moo, o boetse a etelletse pele boiteko ba bohlokoa ba BD, ho fana ka tumello, le ho kopanya machaba le US Sena se kenyelelitse litumellano tse ngata tsa katoloso ea khoebo Europe, Middle East le Afrika, le tumellano ea tšebelisano ea $ 400MM ea ho fana ka tumello, ho nts'etsapele le ho etsa khoebo. agonist ea pele ea GLP-1
- Haufinyane tjena, Monghali Cooley e ne e le CBO bakeng sa Setsi sa Khoebo sa Sofusa se Kimberly-Clark 'me a etella pele boiteko bo atlehileng ba ho rekisa le ho kopanya. Sorrento Therapeutics. O ntse a tsoela pele ho etella pele karolo ea Lymphatic Drug Delivery system ho Sorrento.
- BS
Kwala >
Bill Farley
Motlatsi oa Mopresidente Ntšetso-pele ea Khoebo
- Lilemo tse 30+ tsa boiphihlelo ho Nts'etsopele ea Khoebo, Lithekiso le boikitlaetso bo etelletseng pele molemong oa ho sibolla lithethefatsi, nts'etsopele le tšebelisano 'moho
- Pele a kenela Sorrento, Monghali Farley o kile a tšoara maemo a boetapele ho HitGen, WuXi Apptec, Motlatsi oa Motlatsi oa Motlatsi oa Moaho oa Li-Akhaonto tsa Key le ho etella pele sehlopha sa lefats'e sa BD; ChemDiv, VP ea BD ho, a etella pele boiteko bo bongata ba ho theha lik'hamphani tse ncha tsa kalafo ho CNS, Oncology le Anti-infectives.
- Mong. Farley o sebelitse e le moeletsi ho lihlopha tse fapaneng tsa botsamaisi le li-BOD ho nts'etsapele le ho rekisa matlotlo a kang Xencor, Caliper Technologies le Stratagene.
- O thehile marang-rang a matla ho pholletsa le lik'hamphani tsa meriana, biotech le sechaba sa Venture Capital. Monghali Farley o buile likopanong tse ngata 'me o hatisitsoe likoranteng tse fapaneng tse hlahlobiloeng ke lithaka
- BS
Kwala >
Alexis Nahama
Motlatsi e Moholo oa Mopresidente Neurotherapeutics BU
- Dr. Nahama o etelletse pele mananeo a RTX a ntlafatso ea meriana ea batho le liphoofolo
- E le setho sa sehlopha sa boetapele, Dr. Nahama o ts'ehetsa nts'etsopele ea maano, o okametse merero ea boleng bo holimo, o thusa ho ea boitokisetsong ba 'maraka,' me o holisa boiteko ba ho sebelisana kantle ho naha.
- Ka tjantjello e tsamaisa menyetla ea phetolelo ea ho potlakisa mananeo a nts'etsopele ea batho ha e ntse e tlisa theknoloji eo ho seng joalo e neng e ke ke ea fumaneha ho liphoofolo tse ruuoang lapeng.
- Pele a kenela Sorrento, o qetile lilemo tse fetang 25 a ntse a sebetsa ho Life Sciences le Biotechnology bakeng sa Sanofi, Colgate, Novartis, Merck, VCA Antech le VetStem Biopharma.
- DVM e nang le mosebetsi oa pele o tsepamisitseng maikutlo ho R&D sebakeng sa bohloko (liteko tsa tleliniki bakeng sa liphoofolo tse ruuoang lapeng)
Kwala >